EL7.AI
StocksMediumUpdated×4•Originally published 19 November 2026•Updated 19 November 2026•
4 min read

Shares of 3 insurers fall 5% as Medicare Advantage recoveries estimated at about $9 billion

Key Facts

1Shares of UnitedHealth, CVS Health and Humana fell at least 5% each in the Nov. 18 session.
2CMS estimated recoveries of about $9 billion in improper payments for each audit year, beginning with payment year 2018 audits.
3CMS projected savings of nearly $90 billion and costs of about $378.51 million over 2027–2036.
4In 2025, 46% of Medicare Part C and Part D contracts reported referrals involving fraud, waste or abuse, and 19% reported payment suspensions.
5CMS set Jan. 19, 2027, as the deadline for comments on the CRUSH proposal.

Shares of UnitedHealth, CVS Health and Humana fell at least 5% each in the Nov. 18 session as investors assessed a federal proposal to expand Medicare Advantage audits and renewed political momentum for Medicare for All, according to Dow Jones Newswires via MarketScreener. The proposal estimates potential recoveries of about $9 billion for each audit year as part of a crackdown on improper payments. UnitedHealth closed at $349.91 a share that day, according to EL7 data. The Centers for Medicare & Medicaid Services, known as CMS, introduced the CRUSH proposal on Nov. 16, 2026. The regulatory move puts insurers facing a potential expansion of audits and reporting across programs that cover millions of beneficiaries.

The CRUSH proposal extends beyond Medicare Advantage; it is a standalone rule aimed at strengthening program integrity across Medicare and Medicaid, the Children's Health Insurance Program (CHIP) and the health insurance marketplace. Proposed changes include audits of providers, reporting of overpayments and expanded reporting requirements in managed care programs, according to CMS. The agency estimates that the proposal's quantifiable provisions would save the federal budget nearly $90 billion, with implementation costs of about $378.51 million from 2027 to 2036. CMS said the proposal aims to "strengthen program integrity." The measures combine the recovery of potential payments with tighter oversight of entities participating in public insurance programs and the insurance marketplace.

CMS cited contract data from 2025 in its case for expanded reporting. Some 46% of Medicare Part C and Part D contracts reported referrals to the agency involving confirmed or suspected fraud, waste or abuse. Another 19% of contracts reported suspending payments based on credible allegations of fraud. The proposal would require Medicare Advantage organizations and Part D sponsors to refer all confirmed or suspected cases of fraud, waste and abuse to CMS. It would also expand reporting of payment suspensions from pharmacies to all types of providers and suppliers.

In its Medicare Advantage audit provisions, CMS proposes applying extrapolation to Risk Adjustment Data Validation, or RADV, audits beginning with payment year 2018 audits. The agency estimates that recoveries under this approach could reach about $9 billion for each audit year. The figure refers to estimated potential recoveries of improper payments for an audit year, not collections already made. The mechanism is part of the financial impact CMS expects from the proposal, alongside reporting and oversight requirements. More than 34 million people received Medicare benefits through Medicare Advantage in 2025, representing more than half of all Medicare beneficiaries, according to CMS data.

CMS placed the proposed expansion in the context of efforts it said had delivered rising savings in Medicare program integrity. Savings reported by the agency rose 59%, from $26.3 billion in fiscal year 2024 to a record $41.9 billion in fiscal year 2025. It said the return on every dollar invested in Medicare integrity reached $22.30 in 2025, up 53% from the previous return of $14.60. On the audit front, CMS notified selected Medicare Advantage organizations of their payment year 2023 RADV audits on Nov. 13, 2026. That provides a recent regulatory backdrop for the proposal, which includes expanding recoveries through extrapolation.

The proposal coincides with renewed political debate over Medicare for All. Senator Bernie Sanders said that changing the U.S. healthcare system, which he described as equivalent to 18% of gross domestic product, could not happen overnight. The debate adds a political dimension to the investor reaction that Dow Jones attributed to the federal proposal and momentum for Medicare for All. The next step in the regulatory process is the public comment period on the CRUSH proposal. CMS set Jan. 19, 2027, as the deadline for submitting comments.

Open on chart